ArticleNutrition & metabolism2025
Systemic inflammation index mediated the associations between dietary intake for gut microbiota and muscle mass: a cross-sectional study.
Article in Nutrition & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Gut Microbiota Has the Potential to Improve Sarcopenic Obesity in Menopausal Women by Regulating Estrogen.International journal of women's health · 2026Review
- From "spleen governing muscle" to gut microbiota: mechanisms of sarcopenic obesity in perimenopausal women.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThe associations between a diet that associated with maintaining a healthy gut microbiota and muscle mass, as well as the role of inflammation in these associations, remain unclear. This study aimed to examine the associations between the dietary index for gut microbiota (DI-GM) and muscle mass, and to explore whether the systemic inflammation index (SII) mediates these associations.
methodsA total of 6,908 participants, aged 20 to 59 years, from the 2010-2018 cycles of the National Health and Nutrition Examination Survey, were included in this cross-sectional study. The DI-GM was calculated based on the dietary intake of 13 foods or nutrients, with a higher score indicating a diet associated with a healthier gut microbiota. Muscle mass was assessed using the skeletal muscle mass index (SMI), which was calculated by dividing the appendicular lean mass by the square of height. The SII was calculated by multiplying the platelet count and neutrophil count, and then dividing by the lymphocyte count. Weighted multivariable linear regression models were used to examine the associations between DI-GM and SMI. Mediation analysis was performed to investigate the role of SII in mediating the association between DI-GM and SMI.
resultsEach 1-point increase in DI-GM was associated with a 0.03 (95% CI: 0.01 to 0.04) increase in SMI. The stratified analyses revealed that, with the exception of alcohol consumption, age, gender, race, marital status, education level, income level, smoking status, physical activity, BMI categories, and the history of hypertension, diabetes, cardiovascular disease, or cancer did not modify the association between DI-GM and SMI (P values for all interaction terms >0.05). The positive association between DI-GM and SMI were more pronounced among non-drinkers when comparing the highest quintile to the lowest quintile (β: 0.29; 95% CI: 0.14 to 0.43). SII partially mediated the associations between DI-GM and SMI, with a mediation proportion of 11.6%.
conclusionDI-GM was positively associated SMI, with SII partially mediating this association. These findings suggested that a diet associated with maintaining a healthy gut microbiota may help prevent muscle mass loss by reducing systemic inflammation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.